Page 6 - நாள்பட்ட தடைசெய்யும் நுரையீரல் கோளாறு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cadila Healthcare Ltd Q3FY21 consolidated net profit higher at Rs. 527.2. crore Posted On: CADILA HEALTHCARE LTD. has reported financial results for the period ended December 31, 2020. Financial Results (Q3 FY20-21) - QoQ Comparison The company has reported total income of Rs.3823.1 crores during the period ended December 31, 2020 as compared to Rs.3847.5 crores during the period ended September 30, 2020. The company has posted net profit / (loss) of Rs.527.2 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.473.4 crores for the period ended September 30, 2020. The company has reported EPS of Rs.5.15 for the period ended December 31, 2020 as compared to Rs.4.62 for the period ended September 30, 2020.

United statesDapaglyn dapagliflozinZydus cadilaAmerican associationCadila healthcare ltdTime zoneProfit after taxChronic obstructive pulmonary disorderLong acting muscarinic antagonistNon alcoholic fatty liver diseaseNon alcoholic steatohepatitisLiver diseasesPrimary biliary cholangitisFast track designationOrphan drug designationPegylated interferon